Physician profile
Zbigniew M Szczepiorkowski
NPI 1033142229
$158,392.91
in general payments reported to CMS, 2019-2025
4 companies · $30K in 2025
The $30K reported for 2025 was more than what 93% of Blood Banking & Transfusion Medicine providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $49K · 2021: $13K · 2022: $12K · 2024: $13K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $42K · Travel and Lodging: $945 · Food and Beverage: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $41,900.00 |
| Travel and Lodging | $944.86 |
| Food and Beverage | $116.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols Shared Services North America, INC. | $72,050.23 | 2019-2022 | |
| Fresenius Kabi USA, LLC | $71,962.85 | 2019-2025 | Amicus Separator |
| Grifols Biologicals LLC | $11,906.52 | 2019 | |
| Grifols Therapeutics LLC | $2,473.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zbigniew Szczepiorkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.